Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
    • Agency Watch
    • Medicaid Watch
    • State Watch
    • Rural Health Payout
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
  • Investigations
    • Bill Of The Month
    • Deadly Denials
    • The Body Shops
    • Broken Rehab
    • Guns, Race, and Profit
    • Dead Zone
    • Payback: Tracking Opioid Cash
    • Overpayment Outrage
    • Diagnosis: Debt
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Reset filters
Date
Custom Date Range
Topic
Content Type

Showing 161-180 of 205 results for "Emmarie Huetteman"

Sort by

Biden-Harris Debate Rematch Highlights Health Plan Differences 

By Emmarie Huetteman July 31, 2019 KFF Health News Original

The Wednesday night event marked the second night in a row for Democratic presidential hopefuls to stake claims on how to fix the health care system.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

La revancha del debate Biden-Harris destaca diferencias en los planes de salud

By Emmarie Huetteman July 31, 2019 KFF Health News Original

Hay casi tantas versiones de “Medicare para Todos” como candidatos demócratas, y cada uno piensa que su plan es el camino para asegurar a todos los estadounidenses.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

In A Messy Democratic Presidential Debate, Facts About ‘Medicare For All’ Get Tossed About

By Emmarie Huetteman July 31, 2019 KFF Health News Original

Candidates used their varying views on how to achieve universal coverage — whether through Medicare for All or more incremental steps — as a means to differentiate themselves from the field.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Democrats Favor Building On ACA Over ‘Medicare For All’

By Emmarie Huetteman July 30, 2019 KFF Health News Original

Asked to choose between building on the Affordable Care Act and replacing it with a national Medicare for All plan, 55% of Democrats and Democratic-leaning independents said they would expand the existing law, according to a Kaiser Family Foundation poll released Tuesday.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

GOP Senators Distance Themselves From Grassley And Trump’s Efforts To Cut Drug Prices

By Emmarie Huetteman July 25, 2019 KFF Health News Original

Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes

By Emmarie Huetteman July 24, 2019 KFF Health News Original

Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Watch: Big Week For Drug Pricing Debate Featured On C-SPAN

March 1, 2019 KFF Health News Original

KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers

By Emmarie Huetteman June 28, 2019 KFF Health News Original

A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Universal Health Care For New Yorkers? Not Exactly

By Emmarie Huetteman June 27, 2019 KFF Health News Original

Despite what New York Mayor Bill de Blasio claimed during the first night of the presidential debates, universal health care in the Big Apple is still in the seeding stage.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Investors’ Deep-Pocket Push To Defend Surprise Medical Bills

By Rachel Bluth and Emmarie Huetteman September 11, 2019 KFF Health News Original

As lobbyists purporting to represent doctors and hospitals fight attempts to control surprise medical bills, it has become increasingly clear that the force behind the effort is not just medical professionals, but also investors from private equity firms.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Trump Administration Rule Would Undo Health Care Protections For LGBTQ Patients

By Emmarie Huetteman June 12, 2019 KFF Health News Original

Supporters of the rule say it would strengthen health care professionals’ freedom of conscience, but opponents say it “empowers bad actors to be bad actors.”

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

By Emmarie Huetteman June 11, 2019 KFF Health News Original

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Klobuchar Wants To Stop ‘Pay-For-Delay’ Deals That Keep Drug Prices High

By Emmarie Huetteman April 26, 2019 KFF Health News Original

It’s as shady as it sounds.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Pharma Cash Rolls Into Congress To Defend An Embattled Industry

By Emmarie Huetteman and Jay Hancock and Elizabeth Lucas August 27, 2019 KFF Health News Original

Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Trump Zeroes In On Surprise Medical Bills In White House Chat With Patients, Experts

By Emmarie Huetteman January 23, 2019 KFF Health News Original

Patients and doctors got a chance to share their nightmarish experiences with medical bills with President Donald Trump and other top White House officials.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices

By Julie Rovner February 6, 2019 KFF Health News Original

The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Pharma Execs Dig In For A Fight Against Outraged Senators

By Emmarie Huetteman and Jay Hancock February 26, 2019 KFF Health News Original

The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices

By Emmarie Huetteman and Jay Hancock February 26, 2019 KFF Health News Original

Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Democrats Winning Key Leadership Jobs Have Taken Millions From Pharma

By Emmarie Huetteman November 29, 2018 KFF Health News Original

Top House Republican also received more than $1 million from drugmakers since 2007.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Ideas To Curb Surprise Medical Bills Percolate With Rare Bipartisan Push

By Shefali Luthra and Emmarie Huetteman February 5, 2019 KFF Health News Original

The recent declaration by President Donald Trump that taming unexpected medical bills would be a top priority for his administration echoed through the halls of Congress.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next

More From KFF Health News

A photo of Robert F. Kennedy Jr. at his confirmation hearing in a Senate hearing room.

RFK Jr. Made Promises in Order To Become Health Secretary. He’s Broken Many of Them.

Journalists Unpack Impact of ICE Arrests on Families and Caffeine’s Effect on Dementia Risk

A physician stands in an examination room at a clinic. She has a stethoscope draped over her neck.

Clinics Sour on CMS After Agency Scraps 10-Year Primary Care Program Only Months In

A photo of a White House event: President Trump sits at a table. To the right of him is Robert F. Kennedy Jr. Mehmet Oz sits to Kennedy's right. All three men have microphones across from them.

Trump Team’s Planned ACA Rule Offers Its Answer to Rising Premium Costs: Catastrophic Coverage

KFF

© 2026 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue